Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs
Published in: Drugs 16/2003

01-08-2003 | Review Article

Management of Trigeminal Autonomic Cephalgias and Hemicrania Continua

Authors: Manjit S. Matharu, Christopher J. Boes, Dr Peter J. Goadsby

Published in: Drugs | Issue 16/2003

Login to get access

Abstract

The trigeminal autonomic cephalgias (TACs) are a group of primary headache disorders characterised by unilateral trigeminal distribution pain that occurs in association with ipsilateral cranial autonomic features. This group of headache disorders includes cluster headache, paroxysmal hemicrania and short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT syndrome). Although hemicrania continua has previously been classified amongst the TACs, its nosological status remains unclear. Despite their similarities, these disorders differ in their clinical manifestations and response to therapy, thus underpinning the importance of recognising them. We have outlined the clinical manifestations, differential diagnoses, diagnostic workup and the treatment options for each of these syndromes.
Literature
1.
Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic features, including new cases. Brain 1997; 120: 193–209PubMedCrossRef
2.
Olesen J. Revision of the international headache classification: an interim report. Cephalalgia 2001; 21: 261CrossRef
3.
Headache Classification Committee of The International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8: 1–96CrossRef
4.
Kudrow L. Cluster headache: mechanisms and management. Oxford: Oxford University Press, 1980
5.
Sjaastad O. Cluster headache syndrome. London: WB Saunders, 1992
6.
Lance JW, Goadsby PJ. Mechanism and management of headache. London: Butterworth-Heinemann, 1998
7.
Olesen J, Goadsby PJ. Cluster headache and related conditions. Oxford: Oxford University Press, 1999
8.
Silberstein SD, Lipton RB, Goadsby PJ. Headache in clinical practice. London: Martin Dunitz, 2002
9.
Sjaastad O, Nappi G. Cluster headache syndrome in general practice: basic concepts. London: Smith-Gordon, 2000
10.
11.
Goadsby PJ. Pathophysiology of cluster headache: a trigeminal autonomic cephalgia. Lancet Neurol 2002; 1: 37–43CrossRef
12.
Welch KMA, Goadsby PJ. Chronic daily headache: nosology and pathophysiology. Curr Opin Neurol 2002; 15: 287–95PubMedCrossRef
13.
Koehler PJ. Prevalence of headache in Tulp’s observationes medicae (1641) with a description of cluster headache. Cephalalgia 1993; 13: 318–20PubMedCrossRef
14.
Isler H. Episodic cluster headache from a textbook of 1745: Van Swieten’s classic description. Cephalalgia 1993; 13: 172–4PubMedCrossRef
15.
Boes CJ, Matharu MS, Capabioanco DJ, et al. Wilfred Harris’ early description of cluster headache. Cephalalgia 2002; 22: 320–6PubMedCrossRef
16.
17.
Horton BT, MacLean AR, Craig WM. A new syndrome of vascular headache; results of treatment with histamine: a preliminary report. Proc Mayo Clinic 1939; 14: 250–7
18.
Kunkle EC, Pfieffer J, Wilhoit WM, et al. Recurrent brief headache in cluster pattern. Trans Am Neurol Assoc 1952; 27: 240–3
19.
20.
Bing R. Uber traumatische Erythromelalgie und Erthroprosopalgie. Nervenarzt 1930; 3: 506–12
21.
Romberg MH. Lehrbuch der Nervenkrankheiten des Menschen. Berlin: Dunker, 1840
22.
23.
Ekbom K. Ergotamine tartrate orally in Horton’s ‘histaminic cephalalgia’ (also called Harris’s cilary neuralgia). Acta Psychiatr Scand 1947; 46: 106
24.
Horton BT. Histaminic cephalgia. Lancet 1952; 72: 92–8
25.
Sluder G. The syndrome of sphenopalatine ganglion neurosis. Am J Med 1910; 140: 868–78CrossRef
26.
Vail HH. Vidian neuralgia. Ann Otol Rhinol Laryngol 1932; 41: 837–56
27.
Eulenburg A. Lehrbuch der Nervenkrankheiten. Barlin: Hirschwald, 1878
28.
de Fine Olivarius B. Hemicrania neuralgiformis chronica (chronic migrainous neuralgia). In: Sjaasta d, editor. Proceedings of the Scandinavia Migraine Society Annual Meeting; 1971; 8
29.
D’Alessandro R, Gamberini G, Benassi G, et al. Cluster headache in the Republic of San Marino. Cephalalgia 1986; 6: 159–62PubMedCrossRef
30.
Ford HL, Gerry E, Johnson M, et al. A prospective study of the incidence, prevalence and mortality of multiple sclerosis in Leeds. J Neurol 2002; 249(3): 260–5PubMedCrossRef
31.
Manzoni GC. Gender ratio of cluster headache over the years: a possible role of changes in lifestyle. Cephalalgia 1998; 18: 138–42PubMedCrossRef
32.
Bahra A, May A, Goadsby PJ. Cluster headache: a prospective clinical study in 230 patients with diagnostic implications. Neurology 2002; 58: 354–61PubMedCrossRef
33.
Silberstein SD, Niknam R, Rozen TD, et al. Cluster headache with aura. Neurology 2000; 54: 219–21PubMedCrossRef
34.
35.
Manzoni GC, Micieli G, Granella F, et al. Cluster headache: course over ten years in 189 patients. Cephalalgia 1991; 11: 169–74PubMedCrossRef
36.
Igarashi H, Sakai F. Natural history of cluster headache. Cephalalgia 1996; 16: 390–1
37.
Rosebraugh CJ, Griebel DJ, DiPette DJ. A case report of carotid artery dissection presenting as cluster headache. Am J Med 1997; 102: 418–9PubMedCrossRef
38.
Greve E, Mai J. Cluster headache-like headaches: a symptomatic feature? Cephalalgia 1988; 8: 79–82PubMedCrossRef
39.
Cremer P, Halmagyi GM, Goadsby PJ. Secondary cluster headache responsive to sumatriptan. J Neurol Neurosurg Psychiatry 1995; 59: 633–4PubMedCrossRef
40.
West P, Todman D. Chronic cluster headache associated with a vertebral artery aneurysm. Headache 1991; 31: 210–2PubMedCrossRef
41.
Koenigsberg AD, Solomon GD, Kosmorsky DO. Pseudoaneurysm within the cavernous sinus presenting as cluster headache. Headache 1994; 34: 111–3PubMedCrossRef
42.
Sjaastad O, Horven I, Vennerod AM. A new headache syndrome: headache resembling cluster headache, with recurring bouts of homolateral retrobulbar partial factor XII deficiency, bleeding tendency and a convulsive episode. Headache 1976; 16: 4–10PubMedCrossRef
43.
Mani S, Deeter J. Arteriovenous malformation of the brain presenting as a cluster headache: a case report. Headache 1982; 22: 184–5PubMedCrossRef
44.
Munoz C, Diez-Tejedor E, Frank A, et al. Cluster headache syndrome associated with middle cerebral artery arteriovenous malformation. Cephalalgia 1996; 16: 202–5PubMedCrossRef
45.
Thomas AL. Periodic migrainous neuralgia associated with an arteriovenous malformation. Postgrad Med J 1975; 51: 460–2PubMedCrossRef
46.
Gawel MJ, Willinsky RA, Krajewski A. Reversal of cluster headache side following treatment of arteriovenous malformation. Headache 1989; 29: 453–4PubMedCrossRef
47.
de la Sayette V, SchaefferS,Coskun O, et al. Cluster headache-like attack as an opening symptom of a unilateral infarction of the cervical cord: persistent anaesthesia and dysaesthesia to cold stimuli. J Neurol Neurosurg Psychiatry 1999; 66: 397–400PubMedCrossRef
48.
Cid C, Berciano J, Pascual J. Retro-ocular headache with autonomic features resembling ‘continuous’ cluster headache in a lateral medullary infarction. J Neurol Neurosurg Psychiatry 2000; 69: 134–41PubMedCrossRef
49.
Formisano R, Angelini A, De Vuono G, et al. Cluster-like headache and head injury: case report. Ital J Neurol Sci 1990; 11: 303–5PubMedCrossRef
50.
Tfelt-Hansen P, Paulson OB, Krabbe AE. Invasive adenoma ofthe pituitary gland and chronic migrainous neuralgia: a rare coincidence or a causal relationship? Cephalalgia 1982; 2: 25PubMedCrossRef
51.
Hannerz J. A case of parasellar meningioma mimicking cluster headache. Cephalalgia 1989; 9: 265–9PubMed
52.
Lefevre JP, Simmat G, Bataille B, et al. Cluster headache due to meningioma: 2 cases [letter]. Presse Med 1984; 13: 2323PubMed
53.
Molins A, Lopez M, Codina A, et al. Symptomatic cluster headache: apropos of 4 case reports. Med Clin (Barc) 1989; 92: 181–3
54.
Levyman C, Dagua Filho Ados S, Volpato MM, et al. Epidermoid tumour of the posterior fossa causing multiple facial pain: a case report. Cephalalgia 1991; 11: 33–6PubMedCrossRef
55.
Taub E, Argoff CE, Winterkorn JM, et al. Resolution of chronic cluster headache after resection of a tentorial meningioma: case report. Neurosurgery 1995; 37: 319–21PubMedCrossRef
56.
Kuritzky A. Cluster headache-like pain caused by an upper cervical meningioma. Cephalalgia 1984; 4: 185–6PubMedCrossRef
57.
58.
Heidegger S, Mattfeldt T, Rieber A, et al. Orbito-sphenoidal aspergillus infection mimicking cluster headache: a case report. Cephalalgia 1997; 17: 676–9PubMedCrossRef
59.
Sacquegna T, D’Alessandro R, Cortelli P, et al. Cluster headache after herpes zoster ophthalmicus. Arch Neurol 1982; 39: 384PubMedCrossRef
60.
61.
McKinney AS. Cluster headache developing following ipsilateral orbital exenteration. Headache 1983; 23: 305–6PubMedCrossRef
62.
Prusinski A, Liberski PP, Szulc-Kuberska J. Cluster headache in a patient without a ipsilateral eye. Headache 1985; 25: 134–5PubMedCrossRef
63.
Evers S, Soros P, Brilla R, et al. Cluster headache after orbital exenteration. Cephalalgia 1997; 17: 680–2PubMedCrossRef
64.
Romoli M, Cudia G. Cluster headache due to an impacted superior wisdom tooth: case report. Headache 1988; 28: 135–6PubMedCrossRef
65.
Soros P, Frese A, Husstedt IW, et al. Cluster headache after dental extraction: implications for the pathogenesis of cluster headache? Cephalalgia 2001; 21: 619–22PubMedCrossRef
66.
Goadsby PJ. Raeders syndrome: ‘paratrigeminal’ paralysis of oculo-pupillary sympathetic. J Neurol Neurosurg Psychiatry 2002; 72: 297–9PubMedCrossRef
67.
Dodick DW, Mosek AC, Campbell JK. The hypnic (‘alarm clock’) headache syndrome. Cephalalgia 1998; 18: 152–6PubMedCrossRef
68.
Ekbom K, The Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. N Engl J Med 1991; 325: 322–6CrossRef
69.
Ekbom K, Monstad I, Prusinski A, et al. Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. Acta Neurol Scand 1993; 88: 63–9PubMedCrossRef
70.
Ekbom K, Krabbe A, Micelli G, et al. Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6mg). Cephalalgia 1995; 15: 230–6PubMedCrossRef
71.
Gobel H, Lindner A, Heinze A, et al. Acute therapy for cluster headache with sumatriptan: findings of a one year long-term study. Neurology 1998; 51: 908–11PubMedCrossRef
72.
Manzoni G. Cluster headache and lifestyle: remarks on a population of 374 male patients. Cephalalgia 1999; 19: 88–94PubMedCrossRef
73.
Hardebo JE, Dahlof C. Sumatriptan nasal spray (20mg/dose) in the acute treatment of cluster headache. Cephalalgia 1998; 18: 487–9PubMedCrossRef
74.
van Vliet JA, Bahra A, Martin V, et al. Intranasal sumatriptan is effective in the treatment of acute cluster headache: a double-blind placebo-controlled crossover study. Cephalalgia 2001; 21: 270–1
75.
Schuh-Hofer S, Kinze S, Einhaupl KM, et al. Treatment of acute cluster headache with 20mg sumatriptan nasal spray: an open pilot study. Cephalalgia 2000; 20: 330
76.
Tepper SJ, Rapoport AM, Sheftell FD. Ethical considerations in cluster headache research. Curr Pain Headache Rep 2002; 6: 47–51PubMedCrossRef
77.
Bahra A, Gawel MJ, Hardebo JE, et al. Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology 2000; 54: 1832–9PubMedCrossRef
78.
Dowson AJ, Boes-Hansen S, Farkkila AM. Zolmitriptan nasal spray is fast-acting and highly effective in the acute treatment of migraine. Eur J Neurol 2000; 7: 82
79.
Horton BT. Histaminic cephalalgia: differential diagnosis and treatment. Proc Mayo Clinic 1956; 31: 325–33
80.
Friedman AP, Mikropoulos HE. Cluster headache. Neurol (Minneapolis) 1958; 8: 653–63CrossRef
81.
82.
Fogan L. Treatment of cluster headache: a double blind comparison of oxygen vs air inhalation. Arch Neurol 1985; 42: 362–3PubMedCrossRef
83.
Igarashi H, Sakai F, Tazaki Y. The mechanism by which oxygen interrupts cluster headache. Cephalalgia 1991; 11: 238–9CrossRef
84.
85.
Weiss LD. Treatment of a cluster headache patient in a hyperbaric chamber. Headache 1989; 29: 109–10PubMedCrossRef
86.
Porta M, Granella F, Coppola A, et al. Treatment of cluster headaches with hyperbaric oxygen. Cephalalgia 1991; 11: 236–7
87.
Di Sabato F, Fusco BM, Pelaia P, et al. Hyperbaric oxygen therapy in cluster headache. Pain 1993; 52: 243–5PubMedCrossRef
88.
Nillson Remahl AIM, Ansjon R, Lind F, et al. No prophylactic effect of hyperbaric oxygen during active cluster headache: a double-blind placebo-controlled cross-over study. Cephalalgiav 1997; 17: 456
89.
90.
Costa A, Pucci E, Antonaci F, et al. The effect of intranasal cocaine and lidocaine on nitroglycerin-induced attacks in cluster headache. Cephalalgia 2000; 20: 85–91PubMedCrossRef
91.
Kitrelle JP, Grouse DS, Seybold ME. Cluster headache: local anesthetic abortive agents. Arch Neurol 1985; 42: 496–8CrossRef
92.
Hardebo JE, Einer A. Nerves and vessels in the pterygopalatine fossa and symptoms of cluster headache. Headache 1987; 27: 528–32PubMedCrossRef
93.
94.
95.
Harris W. The facial neuralgias. London: Humphrey Milford Oxford Univerity Press, 1937
96.
Horton BT. The use of histamine in the treatment of specific types of headache. JAMA 1941; 116: 377–83CrossRef
97.
Horton BT, Ryan R, Reynolds JL. Clinical observations of the use of EC110, a new agent for the treatment of headache. Proc Staff Meetings Mayo Clinic 1948; 23: 105–8
98.
Magee KR, Westerberg MR, DeJong RM. Treatment of headache with ergotamine-caffeine suppositories. Neurology 1952; 2: 477–80PubMedCrossRef
99.
Speed WG. Ergotamine tartrate inhalation: a new approach to the management of recurrent vascular headaches. Am J Med Sci 1960; 240: 327–31PubMedCrossRef
100.
Graham JR, Malvea BP, Graham HF. Aerosol ergotamine tartrate for migraine and Horton’ syndrome. N Engl J Med 1960; 263: 802–4PubMedCrossRef
101.
Andersson PG, Jespersen LT. Dihydroergotamine nasal spray in the treatment of attacks of cluster headache. Cephalalgia 1986; 6: 51–4PubMedCrossRef
102.
Sicuteri F, Geppetti P, Marabini S, et al. Pain relief by somatostatin in attacks of cluster headache. Pain 1984; 18: 359–65PubMedCrossRef
103.
Geppetti P, Brocchi A, Caleri D, et al. Somatostatin for cluster headache attack. In: Pfaffenrath V, Lundberg PO, Sjaastad O, editors. Updating in headache. Berlin: Spring-Verlag, 1985: 302–5CrossRef
104.
105.
Meyer JS, Hardenberg J. Clinical effectiveness of calcium entry blockers in prophylactic treatment of migraine and cluster headache. Headache 1983; 23: 266–77PubMedCrossRef
106.
Jonsdottir M, Meyer JS, Rogers RL. Efficacy, side effects and tolerance compared during headache treatment with three different calcium blockers. Headache 1987; 27: 364–9PubMedCrossRef
107.
Gabai IJ, Spierings ELH. Prophylactic treatment of cluster headache with verapamil. Headache 1989; 29: 167–8PubMedCrossRef
108.
Bussone G, Leone M, Peccarisi C, et al. Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache 1990; 30: 411–7PubMedCrossRef
109.
Leone M, D’Amico D, Attanasio A. Verapamil is an effective prophylactic for cluster headache: results of a double-blind multicentre study versus placebo. In: Olesen J, Goadsby PJ, editors. Cluster headache and related conditions. Oxford: Oxford University Press, 1999: 296–9
110.
Singh BN, Nademanee K. Use of calcium antagonists for cardiac arrhythmias. Am J Cardiol 1987; 59: 153 B-62BCrossRef
111.
Naylor WG. Calcium antagonists. London: Academic Press, 1988
112.
Krabbe A, Steiner TJ. Prophylactic treatment of cluster headache. In: Sjaastad O, Nappi G, editors. Cluster headache syndrome in general practice: basic concepts. London: Smith-Gordon, 2000: 91–6
113.
de Carolis P, Baldrati A, Agati R, et al. Nimodipine in episodic cluster headache: results and methodological considerations. Headache 1987; 27: 397–9PubMedCrossRef
114.
de Carolis P, de Capoa D, Agati R, et al. Episodic cluster headache: short and long term results of prophylactic treatment. Headache 1988; 28: 475–6PubMedCrossRef
115.
Ekbom K. Litium rid kroniska symptom av cluster headache. Opusc Med 1974; 19: 148–56
116.
117.
118.
Mathew NT. Clinical subtypes of cluster headache and response to lithium therapy. Headache 1978; 18: 26–30CrossRef
119.
120.
Wyant GM, Ashenhurst EM. Chronic pain syndromes and their treatment: I, cluster headache. Can Anaesth Soc J 1979; 26: 38–41PubMedCrossRef
121.
Szulc-Kuberska J, Klimek A. Lithium treatment of chronic Horton’s headaches. Neurol Neurochir Pol 1978; 12: 409–11PubMed
122.
Savoldi F, Nappi G, Bono G. Lithium salts in the treatment of cluster headache. Riv Neurol 1979; 49: 128–39PubMed
123.
Bussone G, Boiardi A, Merati B, et al. Chronic cluster headache: response to lithium treatment. J Neurol 1979; 221: 181–5PubMedCrossRef
124.
Klimek K, Szulc-Kuberska J, Kawiorski S. Lithium therapy in cluster headache. Eur Neurol 1979; 18: 267–8PubMedCrossRef
125.
Medina JL, Fareed J, Diamond S. Lithium carbonate therapy for cluster headache: changes in number of platelets and serotonin and histamine levels. Arch Neurol 1980; 37: 559–63PubMedCrossRef
126.
Damasio H, Lyon L. Lithium carbonate in the treatment of cluster headache. J Neurol 1980; 224: 1–8PubMedCrossRef
127.
Ekbom K. Lithium for cluster headache: review of the literature and preliminary results of long-term treatment. Headache 1981; 21: 132–9PubMedCrossRef
128.
Manzoni GC, Bono G, Lanfranchi M, et al. Lithium carbonate in cluster headache: assessment of its short- and long-term therapeutic efficacy. Cephalalgia 1983; 3: 109–14PubMedCrossRef
129.
Ekbom K, Solomon S. Management of cluster headache. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. 2nd ed. Philadelphia (PA): Lippincott, Williams & Wilkins; 2000: 731–40
130.
Steiner TJ, Hering R, Couturier EGM, et al. Double-blind placebo controlled trial of lithium in episodic cluster headache. Cephalalgia 1997; 17: 673–5PubMedCrossRef
131.
Nilsson Remahl AIM, Laudon Meyer E, Cordonnier CS, et al. Placebo response rates in cluster headache trials: a review. Cephalalgia. In press
132.
Sicuteri F. Prophylactic and therapeutic properties of 1-methylysergic acid butanolamide in migraine: preliminary report. Int Arch Allergy 1959; 15: 300–7PubMedCrossRef
133.
Dalsgaard-Neilsen T. Uber die prophylaktische Behandlung der Migraine mit Deseril. Praxis 1960; 49: 867–8
134.
Friedman AP. Clinical observations with 1-Methyl-lysergic acid butanolamide (UML-491) in vascular headache. Angiology 1960; 11: 364–6PubMedCrossRef
135.
Graham JR. Use of a new compound, UML-491 (1-Methyl-D-lysergic acid butanolamide), in the prevention of various types of headache. N Engl J Med 1960; 263: 1273–7PubMedCrossRef
136.
Heyck H. Serotoninantagonisten in der behandlung der migraine und der erythroprosopalgic bings oder des horton-syndroms. Schweiz Med Wochenschr 1960; 90: 203–9PubMed
137.
Friedman AP, Losin S. Evaluation of UML-491 in the treatment of vascular headache. Arch Neurol 1961; 4: 241–5PubMedCrossRef
138.
Harris MC. Prophylactic treatment of migraine and histamine cephalgia with a serotonin antagonist (methysergide). Ann Allergy 1961; 19: 500–4PubMed
139.
Ekbom KA. Treatment of migraine, Horton’s syndome and restless legs with Deseril (UML-491). Acta Neurol Scand 1962; 38: 313–8CrossRef
140.
Curran DA, Hinterberger H, Lance JW. Methysergide. Res Clin Stud Headache 1967; 1: 74–122
141.
Krabbe A. Limited efficacy of methysergide in cluster headache: a clinical experience. Cephalalgia 1989; 9 Suppl. 10: 404–5
142.
Graham JR, Suby HI, LeCompte PR, et al. Fibrotic disorders associated with methysergide therapy for headache. N Engl J Med 1966; 274: 360–8CrossRef
143.
Raskin NH. Headache. New York: Churchill-Livingstone, 1988
144.
145.
Berde B, Schild HO. Ergot alkaloids and related compounds. Berlin: Springer-Verlag, 1978CrossRef
146.
Garrison JC. Histamine, bradykinin, 5-hydroxytryptamine and their antagonists. In: Gilman AG, Rall TW, Niles AS, et al., editors. The pharmacological basis of therapeutics. New York: Pergamon Press, 1990: 595
147.
148.
Blakeborough P, Fowler PA, Ashford EA. The use of sumatriptan in patients taking migraine prophylactic agents. Cephalalgia 1993; 13: 163
149.
Liston H, Bennett L, Usher B, et al. The association of the combination of sumatriptan and methysergide in myocardial infarction in a premenopausal woman. Arch Intern Med 1999; 159: 511–3PubMedCrossRef
150.
Tfelt-Hansen P, Bredberg U, Eyjolfsdottii GS, et al. Kinetics of methysergide and its main metabolite, methylergometrine, in man. Cephalalgia 1985; 5: 54–5
151.
Mather P, Silberstein SD, Schulman E, et al. The treatment of cluster headache with repetitive intravenous dihydroergotamine. Headache 1991; 31: 525–32PubMedCrossRef
152.
Sicuteri F, Franchi G, Del Bianco PL. An antaminic drug, BC 105, in the prophylaxis of migraine. Int Arch Allergy 1967; 31: 78–93PubMedCrossRef
153.
Speight TM, Avery GS. Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches. Drugs 1972; 3: 159–203PubMedCrossRef
154.
Ekbom K. Prophylactic treatment of cluster headache with the new serotonin agonist, BC-105. Acta Neurol Scand 1969; 45: 601–10PubMedCrossRef
155.
Monstad I, Krabbe A, Micieli G, et al. Preemptive oral treatment with sumatriptan during a cluster period. Headache 1995; 35: 607–13PubMedCrossRef
156.
Eekers PJE, Koehler PJ. Naratriptan prophylactic treatment in cluster headache. Cephalalgia 2001; 21: 75–6PubMedCrossRef
157.
158.
Jammes JL. The treatment of cluster headaches with prednisone. Dis Nerv Syst 1975; 36: 375–6PubMed
159.
160.
Anthony M, Draher BN. Mechanism of action of steroids in cluster headache. In: Rose FC, editor. New advances in headache research-2. London: Smith-Gordon, 1992: 271-4
161.
Mirzai R, Chang C, Greenspan A, et al. The pathogenesis of osteonecrosis and the relationships to corticosteroids. J Asthma 1999; 36: 77–95PubMedCrossRef
162.
Hering R, Kuritzky A. Sodium valproate in the treatment of cluster headache: an open clinical trial. Cephalalgia 1989; 9: 195–8PubMed
163.
Freitag FG, Diamond S, Diamond ML, et al. Divalproex sodium in the preventative treatment of cluster headache. Headache 2000; 40: 408
164.
Gallagher RM, Mueller LL, Freitag FG. Divalproex sodium in the treatment of migraine and cluster headaches. J Am Osteopath Assoc 2002; 102: 92–4PubMed
165.
El Amrani M, Massiou H, Bousser MG. A negative trial of sodium valproate in cluster headache: methodological issues. Cephalalgia 2002; 22: 205–8PubMedCrossRef
166.
167.
Forderreuther S, Mayer M, Straube A. Treatment of cluster headache with topiramate: effects and side-effects in five patients. Cepahalalgia 2002; 22: 186–9CrossRef
168.
Ahmed F. Chronic cluster headache responding to gabapentin: a case report. Cephalalgia 2000; 20: 252–3PubMedCrossRef
169.
Tay BA, Ngan Kee WD, Chung DC. Gabapentin for the treatment and prophylaxis of cluster headache. Reg Anesth Pain Med 2001; 26: 373–5PubMed
170.
Leandri M, Luzzani M, Cruccu G, et al. Drug-resistant cluster headache responding to gabapentin: a pilot study. Cephalalgia 2001; 21: 744–6PubMedCrossRef
171.
172.
Waldenlind E, Gustafsson SA, Ekbom K, et al. Circadian secretion of cortisol and melatonin in cluster headache during active cluster periods and remission. J Neurol Neurosurg Psychiatry 1987; 50: 207–13PubMedCrossRef
173.
Leone M, Lucini V, D’Amico D, et al. Twenty-four-hour melatonin and cortisol plasma levels in relation to timing of cluster headache. Cephalalgia 1995; 15: 224–9PubMedCrossRef
174.
May A, Bahra A, Buchel C, et al. Hypothalamic activation in cluster headache attacks. Lancet 1998; 351: 275–8CrossRef
175.
Leone M, D’Amico D, Moschiano F, et al. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia 1996; 16: 494–6PubMedCrossRef
176.
Peres MFP, Rozen TD. Melatonin in the preventative treatment of chronic cluster headache. Cephalalgia 2001; 21: 993–5PubMedCrossRef
177.
Anthony M. Arrest of attacks of cluster headache by local steroid injection of the occipital nerve. In: Rose FC, editor. Migraine: clinical and research advances. London: Karger, 1985: 169–73
178.
Peres MF, Stiles MA, Siow HC, et al. Greater occipital nerve blockade for cluster headache. Cephalalgia 2002; 22: 520–2PubMedCrossRef
179.
180.
Nicolodi M, Sicuteri F, Poggioni M. Hypothalamic modulation of nociception and reproduction in cluster headache: I, therapeutic trials of leuprolide. Cephalalgia 199; 13: 253-7
181.
Sicuteri F, Fusco BM, Marabini S. Beneficial effect of capsaicin application to the nasal mucosa in cluster headache. Clin J Pain 1989; 5: 49–53PubMedCrossRef
182.
Sicuteri F, Faneiullaeci M, Nicolodi M, et al. Substance P theory: a unique focus on the painful and painless phenomena of cluster headache. Headache 1990; 30: 69–79PubMedCrossRef
183.
Marks DR, Rapoport A, Padla D. A double-blind placebocontrolled trial of intra-nasal capsaicin for cluster headache. Cephalalgia 1993; 13: 114–6PubMedCrossRef
184.
Fusco BM, Marabini S, Maggi CA, et al. Preventative effect of repeated nasal applications of capsaicin in cluster headache. Pain 1994; 59: 321–5PubMedCrossRef
185.
Fusco BM, Fiore G, Gallo F, et al. ‘Capsaicin-sensitive’ sensory neurons in cluster headache: pathophysiological aspects and therapeutic indication. Headache 1994; 34: 132–7PubMedCrossRef
186.
Saper JR, Klapper J, Mathew NT, et al. Intranasal civamide for the treatment of episodic cluster headaches. Arch Neurol 2002; 59: 990–4PubMedCrossRef
187.
Caviness VS, O’Brien P. Cluster headache: response to chlor-promazine. Headache 1980; 20: 128–31PubMedCrossRef
188.
D’Andrea G, Perini F, Granella F, et al. Efficacy of transdermal clonidine in short-term treatment of cluster headache: a pilot study. Cephalalgia 1995; 15: 430–3PubMed
189.
Leone M, Attanasio A, Grazzi L, et al. Transdermal clonidine in the prophylaxis of episodic cluster headache: an open study. Headache 1997; 37: 559–60PubMedCrossRef
190.
Tfelt-Hansen P. Prophylactic pharmacotherapy of cluster headache. In: Olesen J, Goadsby PJ, editors. Cluster headache & related conditions. Oxford: Oxford University Press, 1999: 257–63
191.
192.
Monzillo PH, Sanvito WL, Da Costa AR. Cluster-tic syndrome: report of five new cases. Arq Neuropsiquiatr 2000; 58: 518–21PubMedCrossRef
193.
194.
Pascual J, Berciano J. Relief of cluster-tic syndrome by the combination of lithium and carbamazepine. Cephalalgia 1993; 13: 205–6PubMedCrossRef
195.
196.
Kirkpatrick PJ, O’Brien M, MacCabe JJ. Trigeminal nerve section for chronic migrainous neuralgia. Br J Neurosurg 1993; 7: 483–90PubMedCrossRef
197.
Mathew NT, Hurt W. Percutaneous radiofrequency trigeminal gangliorhizolysis in intractable cluster headache. Headache 1988; 28: 328–31PubMedCrossRef
198.
Lovely TJ, Kotsiakis X, Jannetta PJ. The surgical management of chronic cluster headache. Headache 1998; 38: 590–4PubMedCrossRef
199.
Leone M, Franzini A, Bussone G. Stereotatic stimulation of the posterior hypothalamic gray matter in a patient with intractable cluster headache. N Engl J Med 2001; 345: 1428–9PubMedCrossRef
200.
Dodick DW. Report on cutaneous neurostimulation of the occipital nerve. 14th Migraine Trust International Symposium; 2002 Sep 24–26; London
201.
Weiner RL, Reed KL. Peripheral neurostimulation for control of intractable occipital neuralgia. Neuromodulation 1999; 2: 217–22PubMedCrossRef
202.
203.
Sjaastad O, Dale I. A new (?) clinical headache entity ‘chronic paroxysmal hemicrania’. Acta Neurol Scand 1976; 54: 140–59PubMedCrossRef
204.
205.
Blau JN, Engel H. Episodic paroxysmal hemicrania: a further case and review of the literature. J Neurol Neurosurg Psychiatry 1990; 53: 343–4PubMedCrossRef
206.
Newman LC, Gordon ML, Lipton RB, et al. Episodic paroxysmal hemicrania: two new cases and a literature review. Neurology 1992; 42: 964–6PubMedCrossRef
207.
Antonaci F, Sjaastad O. Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations. Headache 1989; 29: 648–56PubMedCrossRef
208.
Rapoport AM, Sheftell FD, Baskin SM. Chronic paroxysmal hemicrania: case report of the second known definite occurrence in a male. Cephalalgia 1981; 1: 67–70PubMedCrossRef
209.
Tehindrazanarivelo AD, Visy JM, Bousser MG. Ipsilateral cluster headache and chronic paroxysmal hemicrania: two case reports. Cephalalgia 1992; 12: 318–20PubMedCrossRef
210.
Joubert J, Powell D, Djikowski J. Chronic paroxysmal hemicrania in a South African black: a case report. Cephalalgia 1987; 7: 193–6PubMedCrossRef
211.
Newman LC, Goadsby PJ. The paroxysmal hemicranias, SUNCT syndrome, and hypnic headache. In: Silberstein SD, Lipton RB, Dalessio DJ, editors. Wolffs headache and other head pain. Oxford: Oxford University Press, 2001: 310–24
212.
Russell D. Paroxysmal hemicrania. In: Olesen J, Goadsby PJ, editors. Cluster headache and related conditions. Oxford: Oxford University Press, 1999: 27–36
213.
214.
Bogucki A, Szymanska R, Braciak W. Chronic paroxysmal hemicrania: lack of a pre-chronic stage. Cephalalgia 1984; 4: 187–9PubMedCrossRef
215.
Pradalier A, Dry J. Chronic paroxysmal hemicrania: treatment with indomethacin and diclofenac. Therapie 1984; 39: 185–8PubMed
216.
Pareja JA. Chronic paroxysmal hemicrania: dissociation of the pain and autonomic features. Headache 1995; 35: 111–3PubMedCrossRef
217.
Pollmann W, Pfaffenrath V. Chronic paroxysmal hemicrania: the first possible bilateral case. Cephalalgia 1986; 6: 55–7PubMedCrossRef
218.
Russell D. Chronic paroxysmal hemicrania: severity, duration and time of occurrence of attacks. Cephalalgia 1984; 4: 53–6PubMedCrossRef
219.
Matharu MS, Goadsby PJ. Post-traumatic chronic paroxysmal hemicrania (CPH) with aura. Neurology 2001; 56: 273–5PubMedCrossRef
220.
Kayed K, Godtlibsen OB, Sjaastad O. Chronic paroxysmal hemicrania, 4: “REM sleep locked” nocturnal headache attacks. Sleep 1978; 1: 91–5PubMed
221.
Veloso GG, Kaup AO, Peres MF, et al. Episodic paroxysmal hemicrania with seasonal variation: case report and the EPH-cluster headache continuum hypothesis. Arq Neuropsiquiatr 2001; 59: 944–7PubMedCrossRef
222.
223.
Newman LC, Herskovitz S, Lipton R, et al. Chronic paroxysmal headache: two cases with cerebrovascular disease. Headache 1992; 32: 75–6PubMedCrossRef
224.
Broeske D, Lenn NJ, Cantos E. Chronic paroxysmal hemicrania in a young child: possible relation to ipsilateral occipital infarction. J Child Neurol 1993; 8: 235–6PubMedCrossRef
225.
226.
Sjaastad O, Stovner LJ, Stolt-Nielsen A, et al. CPH and hemicrania continua: requirements of high dose indomethacin dosages: an ominous sign? Headache 1995; 35: 363–7PubMedCrossRef
227.
Gatzonis S, Mitsikostas DD, Ilias A, et al. Two more secondary headaches mimicking chronic paroxysmal hemicrania: is this the exception or the rule? Headache 1996; 36: 511–3PubMedCrossRef
228.
Mariano HS, Bigal ME, Bordini CA, et al. Chronic paroxysmal hemicrania (CPH)-like syndrome as a first manifestation of cerebral metastasis of parotid epidermoid carcinoma: a case report. Cephalalgia 1999; 19: 442
229.
Delreux V, Kevers L, Callewaert A. Hemicranie paroxystique inaugurant un syndrome de Pancoast. Rev Neurol (Paris) 1989; 145: 151–2
230.
Hannerz J, Jogestrand T. Intracranial hypertension and sumatriptan efficacy in a case of chronic paroxysmal hemicrania which became bilateral. Headache 1993; 33: 320–3PubMedCrossRef
231.
MacMillan JC, Nukada H. Chronic paroxysmal hemicrania. N Z Med J 1989; 102: 251–2PubMed
232.
Pareja J, Pareja J. Chronic paroxysmal hemicrania coexisting with migraine: differential response to pharmacological treatment. Headache 1992; 32: 77–8PubMedCrossRef
233.
234.
Pearce SHS, Cox JGC, Pearce JMS. Chronic paroxysmal hemicrania, episodic cluster headache and classic migraine in one patient. J Neurol Neurosurg Psychiatry 1987; 50: 1699–700PubMedCrossRef
235.
Centonze V, Bassi A, Causarano V, et al. Simultaneous occurrence of ipsilateral cluster headache and chronic paroxysmal hemicrania: a case report. Headache 2000; 40: 54–6PubMedCrossRef
236.
Hannerz J. Trigeminal neuralgia with chronic paroxysmal hemicrania: the CPH-tic syndrome. Cephalalgia 1993; 13: 361–4PubMedCrossRef
237.
Caminero AB, Pareja JA, Dobato JL. Chronic paroxysmal hemicrania-tic syndrome. Cephalalgia 1998; 18: 159–61PubMedCrossRef
238.
Zukerman E, Peres MFP, Kaup AO, et al. Chronic paroxysmal hemicrania-tic syndrome. Neurology 2000; 54: 1524–6PubMedCrossRef
239.
Martinez-Salio A, Porta-Etessam J, Perez-Martinez D, et al. Chronic paroxysmal hemicrania-tic syndrome. Headache 2000; 40: 682–5PubMedCrossRef
240.
Mateo I, Pascual J. Coexistence of chronic paroxysmal hemicrania and benign cough headache. Headache 1999; 39: 437–8PubMedCrossRef
241.
Boes CJ, Matharu MS, Goadsby PJ. The paroxysmal hemicrania-tic syndrome. Cephalalgia 2003; 23(1): 24–8PubMedCrossRef
242.
Antonaci F, Pareja JA, Caminero AB, et al. Chronic paroxysmal hemicrania and hemicrania continua: parenteral indomethacin: the ‘Indotest’. Headache 1998; 38: 122–8PubMedCrossRef
243.
Kudrow DB, Kudrow L. Successful aspirin prophylaxis in a child with chronic paroxysmal hemicrania. Headache 1989; 29: 280–1PubMedCrossRef
244.
Durko A, Klimek A. Naproxen in the treatment of chronic paroxysmal hemicrania. Cephalalgia 1987; 7: 361–2
245.
Sjaastad O, Antonaci F. A piroxicam derivative partly effective in chronic paroxysmal hemicrania and hemicrania continua. Headache 1995; 35: 549–50PubMedCrossRef
246.
Mathew NT, Kailasam J, Fischer A. Responsiveness to celecoxib in chronic paroxysmal hemicrania. Neurology 2000; 55: 316PubMedCrossRef
247.
Shabbir N, McAbee G. Adolescent chronic paroxysmal hemicrania responsive to verapamil monotherapy. Headache 1994; 34: 209–10PubMedCrossRef
248.
Evers S, Husstedt IW. Alternatives in drug treatment of chronic paroxysmal hemicrania. Headache 1996; 36: 429–32PubMedCrossRef
249.
Coria F, Claveria LE, Jimenez-Jimenez FJ, et al. Episodic paroxysmal hemicrania responsive to calcium channel blockers. J Neurol Neurosurg Psychiatry 1992; 55: 166PubMedCrossRef
250.
Warner JS, Wamil AW, McLean MJ. Acetazolamide for the treatment of chronic paroxysmal hemicrania. Headache 1994; 34: 597–9PubMedCrossRef
251.
Hannerz J, Ericson K, Bergstrand G. Chronic paroxysmal hemicrania: orbital phlebography and steroid treatment. Cephalalgia 1987; 7: 189–92PubMedCrossRef
252.
Pareja JA, Caminero AB, Franco E, et al. Dose, efficacy and tolerability of long-term indomethacin treatment of chronic paroxysmal hemicrania and hemicrania continua. Cephalalgia 2001; 21: 869–78CrossRef
253.
Sjaastad O, Russell D, Horven I, et al. Multiple neuralgiform unilateral headache attacks associated with conjunctival injection and appearing in clusters: a nosological problem. Proceedings of the Scandinavian Migraine Society; 1978; Arhus, 31
254.
Sjaastad O, Saunte C, Salvesen R, et al. Shortlasting unilateral neuralgiform headache attacks with conjunctival injection, tearing, sweating, and rhinorrhea. Cephalalgia 1989; 9:147–56PubMed
255.
256.
De Benedittis G. SUNCT syndrome associated with cavernous angioma of the brain stem. Cephalalgia 1996; 16: 503–6PubMedCrossRef
257.
Benoliel R, Sharav Y. SUNCT syndrome: case report and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 158–61PubMedCrossRef
258.
259.
D’Andrea G, Granella F, Cadaldini M. Possible usefulness of lamotrigine in the treatment of SUNCT syndrome. Neurology 1999; 53: 1609PubMedCrossRef
260.
May A, Bahra A, Buchel C, et al. Functional MRI in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing. Ann Neurol 1999; 46: 791–3PubMedCrossRef
261.
Ertsey C, Bozsik G, Afra J, et al. A case of SUNCT syndrome with neurovascular compression. Cephalalgia 2000; 20: 325CrossRef
262.
263.
Lain AH, Caminero AB, Pareja JA. SUNCT syndrome; absence of refractory periods and modulation of attack duration by lengthening of the trigger stimuli. Cephalalgia 2000; 20: 671–3PubMedCrossRef
264.
Leone M, Rigamonti A, Usai S, et al. Two new SUNCT cases responsive to lamotrigine. Cephalalgia 2000; 20: 845–7PubMedCrossRef
265.
Morales-Asin F, Espada F, Lopez-Obarrio LA, et al. A SUNCT case with response to surgical treatment. Cephalalgia 2000; 20: 67–8PubMedCrossRef
266.
Moris G, Ribacoba R, Solar DN, et al. SUNCT syndrome and seborrheic dermatitis associated with craneosynostosis. Cephalalgia 2001; 21: 157–9PubMedCrossRef
267.
Penart A, Firth M, Bowen JRC. Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) following presumed dorsolateral brainstem infarction. Cephalalgia 2001; 21: 236–9PubMedCrossRef
268.
Sabatowski R, Huber M, Meuser T, et al. SUNCT syndrome: a treatment option with local opioid blockade of the superior cervical ganglion? Cephalalgia 2001; 21: 154–6PubMedCrossRef
269.
Sesso RM. SUNCT syndrome or trigeminal neuralgia with lacrimation and conjunctival injection? Cephalalgia 2001; 21: 151–3PubMedCrossRef
270.
ter Berg HWM, Goadsby PJ. Significance of atypical presentation of symptomatic SUNCT: a case report. J Neurol Neurosurg Psychiatry 2001; 70: 244–6PubMedCrossRef
271.
Montes E, Alberca R, Lozano P, et al. Status like SUNCT in two young women. Headache 2001; 41: 826–9PubMedCrossRef
272.
D’Andrea G, Granella F, Ghiotto N, et al. Lamotrigine in the treatment of SUNCT syndrome. Neurology 2001; 57: 1723–5PubMedCrossRef
273.
D’Andrea G, Granella F. SUNCT syndrome: the first case in childhood. Cephalalgia 2001; 21: 701–2PubMedCrossRef
274.
Black DF, Dodick DW. Two cases of medically and surgically intractable SUNCT: a reason for caution and an argument for a central mechanism. Cephalalgia 2002; 22: 201–4PubMedCrossRef
275.
Hannerz J, Linderoth B. Neurosurgical treatment of short-lasting, unilateral, neuralgiform hemicrania with conjunctival injection and tearing. Br J Neurosurg 2002; 16: 55–8PubMedCrossRef
276.
Matharu MS, Boes CJ, Goadsby PJ. SUNCT syndrome: prolonged attacks, refractoriness and response to topiramate. Neurology 2002; 58: 1307PubMedCrossRef
277.
Porta-Etessam J, Martinez-Salio A, Berbel A, et al. Gabapentin (neurontin) in the treatment of SUNCT syndrome. Cephalalgia 2002; 22: 249PubMedCrossRef
278.
Pareja JA, Ming JM, Kruszewski P, et al. SUNCT syndrome: duration, frequency and temporal distribution of attacks. Headache 1996; 36: 161–5PubMedCrossRef
279.
Pareja JA, Joubert J, Sjaastad O. SUNCT syndrome: atypical temporal patterns. Headache 1996; 36: 108–10PubMedCrossRef
280.
Pareja JA, Pareja J, Palomo T, et al. SUNCT syndrome: repetitive and overlapping attacks. Headache 1994; 34:114–6vPubMedCrossRef
281.
Bussone G, Leone M, Volta GD, et al. Short-lasting unilateral neuralgiform headache attacks with tearing and conjunctival injection: the first symptomatic case. Cephalalgia 1991; 11: 123–7PubMedCrossRef
282.
Morales F, Mostacero E, Marta J, et al. Vascular malformation f the cerebellopontine angle associated with SUNCT syndrome. Cephalalgia 1994; 14: 301–2PubMedCrossRef
283.
Levy MJ, Matharu MS, Goadsby PJ. Prolactinomas, dopamine agonists and headache: two cases reports. Eur J Neurol 2003; 10(2): 169–73PubMedCrossRef
284.
Ferrari MD, Haan J, van Seters AP. Bromocriptine-induced trigeminal neuralgia attacks in a patient with pituitary tumor. Neurology 1988; 38: 1482–4PubMedCrossRef
285.
Massiou H, Launay JM, Levy C, et al. SUNCT syndrome in two patients with prolactinomas and bromocriptine-induced attacks. Neurology 2002; 58: 1698–9PubMedCrossRef
286.
Levy MJ, Jager HR, Matharu MS, et al. Pituitary tumours and headache: does size matter? Cephalalgia 2002; 22: 592
287.
Sjaastad O, Kruszewski P. Trigeminal neuralgia and ‘SUNCT’ syndrome: similarities and differences in the clinical picture. Funct Neurol 1992; 7: 103–7PubMed
288.
Goadsby PJ, Matharu MS, Boes CJ. SUNCT syndrome or trigeminal neuralgia with lacrimation. Cephalalgia 2001; 21: 82–3PubMedCrossRef
289.
Pareja JA, Ruiz J, Deisla C, et al. Idiopathic stabbing headache (jabs and jolts syndrome). Cephalalgia 1996; 16: 93–6PubMedCrossRef
290.
Pareja JA, Kruszewski P, Caminero AB. SUNCT syndrome versus idiopathic stabbing headache (jabs and jolts syndrome). Cephalalgia 1999; 19: 46–8PubMed
291.
Pareja JA, Kruszewski P, Sjaastad O. SUNCT syndrome: trials of drugs and anesthetic blockades. Headache 1995; 35: 138–42PubMedCrossRef
292.
Peatfield R, Bahra A, Goadsby PJ. Trigeminal-autonomic cephalgias (TACs). Cephalalgia 1998; 18: 358–61PubMedCrossRef
293.
Guitierrez-Garcia JM. SUNCT syndrome responsive to lamo-trigine. Headache 2002; 42: 823–5CrossRef
294.
295.
Lenaerts M, Diederich N, Phuoe D. A patient with SUNCT cured by the Jannetta procedure. Cephalalgia 1997; 17: 460
296.
Gardella L, Viruega A, Rojas H, et al. A case of a patient with SUNCT syndrome treated with Jannetta procedure. Cephalalgia 2001; 21: 996–9PubMedCrossRef
297.
Medina JL, Diamond S. Cluster headache variant: spectrum of a new headache syndrome. Arch Neurol 1981; 38: 705–9PubMedCrossRef
298.
Sjaastad O, Spierings EL. Hemicrania continua: another headache absolutely responsive to indomethacin. Cephalalgia 1984; 4: 65–70PubMedCrossRef
299.
Peres MFP, Silberstein SD, Nahmias S, et al. Hemicrania continua is not that rare. Neurology 2001; 57: 948–51PubMedCrossRef
300.
Wheeler SD, Allen KF, Pusey T. Is hemicrania continua a migraine variant? Cephalalgia 2001; 21: 508
301.
Pasquier F, Leys D, Petit H. Hemicrania continua: the first bilateral case. Cephalalgia 1987; 7: 169–70PubMedCrossRef
302.
Iordanidis T, Sjaastad O. Hemicrania continua: a case report. Cephalalgia 1989; 9: 301–3PubMed
303.
Trucco M, Antonaci F, Sandrini G. Hemicrania continua: a case responsive to piroxicam-beta-cyclodextrin. Headache 1992; 32: 39–40PubMedCrossRef
304.
Newman LC, Lipton RB, Russell M, et al. Hemicrania continua: attacks may alternate sides. Headache 1992; 32: 237–8PubMedCrossRef
305.
Bordini C, Antonaci F, Stovner LJ, et al. ‘Hemicrania continua’: a clinical review. Headache 1991; 31: 20–6PubMedCrossRef
306.
Newman LC, Lipton RB, Solomon S. Hemicrania continua: ten new cases and a review of the literature. Neurology 1994; 44: 2111–4PubMedCrossRef
307.
308.
Pareja JA. Hemicrania continua: remitting stage evolved from the chronic form. Headache 1995; 35: 161–2PubMedCrossRef
309.
Brilla R, Evers S, Soros P, et al. Hemicrania continua in an HIV-infected outpatient. Cephalalgia 1998; 18: 287–8PubMedCrossRef
310.
Antonaci F, Sjaastad O. Hemicrania continua: a possible symptomatic case, due to mesenchymal tumor. Funct Neurol 1992; 7: 471–4PubMed
311.
312.
Goadsby PJ, Boes CJ. New daily persistent headache. J Neurol Neurosurg Psychiatry 2002; 72 Suppl. II: ii6–9PubMed
313.
Young WB, Silberstein SD. Hemicrania continua and symptomatic mediation overuse. Headache 1993; 33: 485–7PubMedCrossRef
314.
Sjaastad O, Joubert J, Elsas T, et al. Hemicrania continua and cervicogenic headache: separate headaches or two faces of the same headache? Funct Neurol 1993; 8: 79–83PubMed
315.
316.
Espada F, Escalza I, Morales-Asin F, et al. Hemicrania continua: nine new cases. Cephalalgia 1999; 19: 442
317.
318.
319.
320.
Bigal ME, Tepper SJ, Rapoport AM, et al. Hemicrania continua: comparison between two different classification systems. Cephalalgia 2002; 22: 242–5PubMedCrossRef
321.
322.
May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiological implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 1999; 19: 115–27PubMedCrossRef
323.
May A, Buchel C, Turner R, et al. MR-angiography in facial and other pain: neurovascular mechanisms of trigeminal sensation. J Cereb Blood Flow Metab 2001; 21: 1171–6PubMedCrossRef
324.
Benoliel R, Sharav Y. Trigeminal neuralgia with lacrimation or SUNCT syndrome? Cephalalgia 1998; 18: 85–90PubMedCrossRef
325.
Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995; 1: 658–60PubMedCrossRef
326.
Bahra A, Matharu MS, Buchel C, et al. Brainstem activation specific to migraine headache. Lancet 2001; 357: 1016–7PubMedCrossRef
327.
May A, Kaube H, Buechel C, et al. Experimental cranial pain elicited by capsaicin: a PET-study. Pain 1998; 74: 61–6PubMedCrossRef
328.
Malick A, Burstein R. Cells of origin of the trigeminohy-pothalamic tract in the rat. J Comp Neurol 1998; 400: 125–44PubMedCrossRef
Metadata
Title
Management of Trigeminal Autonomic Cephalgias and Hemicrania Continua
Authors
Manjit S. Matharu
Christopher J. Boes
Dr Peter J. Goadsby
Publication date
01-08-2003
Publisher
Springer International Publishing
Published in
Drugs / Issue 16/2003
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-200363160-00002

Other articles of this Issue 16/2003

Drugs 16/2003 Go to the issue

Leading Article

Breakthroughs in the Management of Multiple Myeloma

Adis Drug Profile

Atazanavir

Adis Drug Evaluation

Insulin Glargine

Adis Drug Profile

Atazanavir

Adis Drug Profile

Atazanavir

Adis Drug Evaluation

Carvedilol